Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management
The peptides specific targeting of NNMT-expressing adipocytes allows for a localized metabolic shift without widespread systemic overstimulation, presenting a unique model for selective fat mass modulation studies
This core testing panel includes essential evaluations of metabolic function, cholesterol, thyroid health, inflammation markers, and more, giving us a clear picture of your fundamental health state
Some common areas that pain occurs is in the neck and parts of the hand
A PubMed Central-hosted review of peptide-based obesity treatments describes "nausea, vomiting and loss of appetite" as common effects of the GLP-1 drug class (pmc.ncbi.nlm.nih.gov)